See All Slides - tctmd.com

Slides

Presentation TCT 2012

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

Presenter: Dimitri Karmpaliotis

October 22, 2012

Presentation TCT 2012

Case 1: PCI in STEMI

Presenter: Alexey Protopopov

October 22, 2012

Presentation TCT 2012

Complex Left Main PCI Requiring Hemodynamic Support

Presenter: Jan Harnek

October 22, 2012

Presentation TCT 2012

Making PFO Closure the Lowest Risk Interventional Procedure: Devices and Techniques

Presenter: Horst Sievert

October 22, 2012

Presentation TCT 2012

Introduction(14)

Presenter: Sigmund Silber

October 22, 2012

Presentation TCT 2012

Simultaneous Localization and Treatment of Vulnerable Plaque by Tin-117m Conversion Electrons: First-in-Human Results

Presenter: Renu Virmani

October 22, 2012

Presentation TCT 2012

Should Interventionalists Even Assess Post-PCI Biomarkers (CKMB, Troponins, or ECGs)?

Presenter: Allan Jaffe

October 22, 2012

Presentation TCT 2012

Evidence/Practice Intersection: What We Know, What We Don't, and How to Treat

Presenter: Martin Leon

October 22, 2012

Presentation TCT 2012

Uses of Drug-Eluting Balloons for Coronary Bifurcation Lesions: Rationale, Data, and Practice

Presenter: Detlef Mathey

October 22, 2012

Presentation TCT 2012

Intravascular Photoacoustics: Progress and Potential for Vulnerable Plaque Imaging

Presenter: Antonius van der Steen

October 22, 2012

Advertisement

Slides

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

Case 1: PCI in STEMI

Complex Left Main PCI Requiring Hemodynamic Support

Making PFO Closure the Lowest Risk Interventional Procedure: Devices and Techniques

Introduction(14)

Simultaneous Localization and Treatment of Vulnerable Plaque by Tin-117m Conversion Electrons: First-in-Human Results

Should Interventionalists Even Assess Post-PCI Biomarkers (CKMB, Troponins, or ECGs)?

Evidence/Practice Intersection: What We Know, What We Don't, and How to Treat

Uses of Drug-Eluting Balloons for Coronary Bifurcation Lesions: Rationale, Data, and Practice

Intravascular Photoacoustics: Progress and Potential for Vulnerable Plaque Imaging

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content